Can Seegene’s million-case GMCS establish a new standard for HPV and STI testing?
Seegene will test whether combined HPV and STI PCR panels can improve reproductive infection care through its million-case GMCS.
Seegene will test whether combined HPV and STI PCR panels can improve reproductive infection care through its million-case GMCS.
Teal Health and UC Davis Health test how FDA-authorized at-home HPV screening can fit routine care and reach overdue patients.